Multivariable analysis of allografted patients
| Factor . | PFS . | OS . | ||
|---|---|---|---|---|
| HR (95% CI) . | P . | HR (95% CI) . | P . | |
| Status at alloSCT | ||||
| PR versus CR | 2.76 (1.22-6.25) | .015 | 2.96 (1.00-8.82) | .051 |
| SD, PD versus CR | 5.39 (2.33-12.49) | < .001 | 5.72 (1.97-16.56) | .001 |
| GVHD | ||||
| No versus chronic | 1.68 (.93-3.00) | .084 | 3.41 (1.53-7.58) | .003 |
| Acute versus chronic | 2.51 (1.37-4.62) | .003 | 4.14 (1.85-9.28) | < .001 |
| Factor . | PFS . | OS . | ||
|---|---|---|---|---|
| HR (95% CI) . | P . | HR (95% CI) . | P . | |
| Status at alloSCT | ||||
| PR versus CR | 2.76 (1.22-6.25) | .015 | 2.96 (1.00-8.82) | .051 |
| SD, PD versus CR | 5.39 (2.33-12.49) | < .001 | 5.72 (1.97-16.56) | .001 |
| GVHD | ||||
| No versus chronic | 1.68 (.93-3.00) | .084 | 3.41 (1.53-7.58) | .003 |
| Acute versus chronic | 2.51 (1.37-4.62) | .003 | 4.14 (1.85-9.28) | < .001 |
PFS indicates progression-free survival; OS, overall survival; HR, hazard ratio; CI, confidence interval; alloSCT, allogeneic transplantation; PR, partial remission; CR, complete remission; SD, stable disease; PD, progressive disease; and GVHD, graft-versus-host disease.